Trial Profile
POSTOPERATIVE OUTCOMES FOLLOWING PROPHYLACTIC INTRAVITREAL DEXAMETHASONE IMPLANT(OZURDEX) VERSUS ORAL STEROIDS ALONGWITH CATARACT SURGERY: A RANDOMIZED CLINICAL TRIAL
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Intermediate uveitis; Posterior uveitis
- Focus Therapeutic Use
- Sponsors Allergan
- 12 Dec 2017 New trial record